A real-world chronic myelogenous leukemia (CML) patient disease registry
Novartis CABL001J1US01 (ASC4REAL-2) – A real-world chronic myelogenous leukemia (CML) patient disease registry to describe patient experience and clinical outcomes among patients with CML receiving approved first or second line tyrosine kinase inhibitor (TKI) therapy (NCT07091019)
Principal Investigator(s)
Joshua R. Dower, MD
Location
Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-358-8879
Stamford, CT 06902
Main: 203-358-8879